{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:08:47Z","timestamp":1777554527423,"version":"3.51.4"},"reference-count":80,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:p>We are entering a new stage of the severe acute respiratory syndrome coronavirus 2 pandemic with the initiation of large-scale vaccination programs globally. In these circumstances, even rare adverse effects of vaccines may be encountered more often, if millions of people are to be vaccinated in a short period. Vaccination has the potential for causing cutaneous adverse effects. Thus, it is paramount that dermatologists worldwide are acquainted with the possible skin reaction patterns to the coming vaccines. Herein, we conduct a review to discuss the most frequent cutaneous adverse effects of vaccines and their management, with a particular focus on the expected adverse reactions for the coming severe acute respiratory syndrome coronavirus 2 vaccines, such as local reactions, as well as immediate- and delayed-type hypersensitivity reactions, including erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrosis, serum sickness\u2013like reactions, and vasculitides. We also discuss the yet unanswered questions on vaccines for which we may soon be asked to provide an expert opinion.<\/jats:p>","DOI":"10.1097\/der.0000000000000755","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T22:08:19Z","timestamp":1618438099000},"page":"133-139","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":12,"title":["Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Cutaneous Adverse Reactions: A Review"],"prefix":"10.1177","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7672-0395","authenticated-orcid":false,"given":"Miguel","family":"Alpalh\u00e3o","sequence":"first","affiliation":[{"name":"From the, *Dermatology Department, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte EPE"},{"name":"Dermatology Universitary Clinic, Faculty of Medicine"},{"name":"Dermatology Research Unit, iMM Jo\u00e3o Lobo Antunes, University of Lisbon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Maia-Silva","sequence":"additional","affiliation":[{"name":"From the, *Dermatology Department, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte EPE"},{"name":"Dermatology Universitary Clinic, Faculty of Medicine"},{"name":"Dermatology Research Unit, iMM Jo\u00e3o Lobo Antunes, University of Lisbon"},{"name":"Dermatology Department, Hospital CUF Descobertas, Lisbon, Portugal."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Filipe","sequence":"additional","affiliation":[{"name":"From the, *Dermatology Department, Hospital de Santa Maria, Centro Hospitalar Universit\u00e1rio Lisboa Norte EPE"},{"name":"Dermatology Universitary Clinic, Faculty of Medicine"},{"name":"Dermatology Research Unit, iMM Jo\u00e3o Lobo Antunes, University of Lisbon"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"issue":"11","key":"e_1_3_1_2_2","first-page":"2113","article-title":"Vaccine adverse events: separating myth from reality","volume":"66","author":"Kimmel SR.","year":"2002","unstructured":"Kimmel SR. Vaccine adverse events: separating myth from reality. Am Fam Physician, 2002; 66(11):2113\u20132120.","journal-title":"Am Fam Physician"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389"},{"issue":"1","key":"e_1_3_1_4_2","first-page":"e17","article-title":"Aluminum granuloma in a child secondary to DTaP-IPV vaccination: a case report","volume":"36","author":"Haag CK","year":"2019","unstructured":"Haag CK, , Dacey E, , Hamilton N, et al. Aluminum granuloma in a child secondary to DTaP-IPV vaccination: a case report. Pediatr Dermatol, 2019; 36(1):e17\u2013e19.","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"e_1_3_1_5_2","first-page":"182","article-title":"Subcutaneous nodule after vaccination with an aluminum-containing vaccine","volume":"17","author":"Avcin S","year":"2008","unstructured":"Avcin S, , Jazbec J, , Jancar J. Subcutaneous nodule after vaccination with an aluminum-containing vaccine. Acta Dermatovenerol Alp Pannonica Adriat, 2008; 17(4):182\u2013184.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"4","key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1111\/ijd.12751","article-title":"Nicolau syndrome after benzathine penicillin treated with hyperbaric oxygen therapy","volume":"54","author":"Lopes L","year":"2015","unstructured":"Lopes L, , Filipe P, , Alves A, et al. Nicolau syndrome after benzathine penicillin treated with hyperbaric oxygen therapy. Int J Dermatol, 2015; 54(4):e103\u2013e106.","journal-title":"Int J Dermatol"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8229.94017"},{"issue":"38","key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.3346\/jkms.2020.35.e337","article-title":"Vaccine-related anaphylaxis cases confirmed by KCDC from 2001\u20132016","volume":"35","author":"Roh EJ","year":"2020","unstructured":"Roh EJ, , Lee MH, , Song KB, et al. Vaccine-related anaphylaxis cases confirmed by KCDC from 2001\u20132016. J Korean Med Sci, 2020; 35(38):e337.","journal-title":"J Korean Med Sci"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.112.4.815"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.07.048"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.23822\/EurAnnACI.1764-1489.86"},{"issue":"1","key":"e_1_3_1_12_2","first-page":"1","article-title":"International Consensus (ICON): allergic reactions to vaccines","volume":"9","author":"Dreskin SC","year":"2016","unstructured":"Dreskin SC, , Halsey NA, , Kelso JM, et al. International Consensus (ICON): allergic reactions to vaccines. World Allergy Organ J, 2016; 9(1):1\u201321.","journal-title":"World Allergy Organ J"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0109"},{"issue":"2","key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaip.2020.09.029","article-title":"Polyethylene glycol\u2013induced systemic allergic reactions (anaphylaxis)","volume":"9","author":"Sellaturay P","year":"2021","unstructured":"Sellaturay P, , Nasser S, , Ewan P. Polyethylene glycol\u2013induced systemic allergic reactions (anaphylaxis). J Allergy Clin Immunol Pract, 2021; 9(2):670\u2013675.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.12.003"},{"issue":"7","key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.jaip.2019.05.058","article-title":"Polyethylene glycols and polysorbates: two still neglected ingredients causing true IgE-mediated reactions","volume":"7","author":"Calogiuri G","year":"2019","unstructured":"Calogiuri G, , Foti C, , Nettis E, et al. Polyethylene glycols and polysorbates: two still neglected ingredients causing true IgE-mediated reactions. J Allergy Clin Immunol Pract, 2019; 7(7):2509\u20132510.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"e_1_3_1_17_2","article-title":"Allergic reactions to the first COVID-19 vaccine: a potential role of polyethylene glycol?","author":"Cabanillas B","year":"2020","unstructured":"Cabanillas B, , Akdis C, , Novak N. Allergic reactions to the first COVID-19 vaccine: a potential role of polyethylene glycol? Allergy, 2020. doi: 10.1111\/all.14711. [Epub ahead of print].","journal-title":"Allergy"},{"issue":"01","key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5414\/ALX02215E","article-title":"Severe allergic reactions to the COVID-19 vaccine\u2014statement and practical consequences","volume":"5","author":"Kleine-Tebbe J","year":"2021","unstructured":"Kleine-Tebbe J, , Klimek L, , Hamelmann E, et al. Severe allergic reactions to the COVID-19 vaccine\u2014statement and practical consequences. Allergol Select, 2021; 5(01):26\u201328.","journal-title":"Allergol Select"},{"issue":"3","key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/j.bja.2020.12.020","article-title":"Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?","volume":"126","author":"Garvey LH","year":"2021","unstructured":"Garvey LH, , Nasser S. Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit? Br J Anaesth, 2021; 126(3):e106\u2013e108.","journal-title":"Br J Anaesth"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8686-z"},{"issue":"4","key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1034\/j.1600-0536.2001.440409-16.x","article-title":"Systemic contact dermatitis from cinchocaine","volume":"44","author":"Erdmann SM","year":"2001","unstructured":"Erdmann SM, , Sachs B, , Merk HF. Systemic contact dermatitis from cinchocaine. Contact Dermatitis, 2001; 44(4):246\u2013263.","journal-title":"Contact Dermatitis"},{"issue":"3","key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/15569527.2014.952375","article-title":"Maculopapular rash of unsuspected cause: systemic contact dermatitis to cinchocaine","volume":"34","author":"Matos D","year":"2015","unstructured":"Matos D, , Serrano P, , Brand\u00e3o FM. Maculopapular rash of unsuspected cause: systemic contact dermatitis to cinchocaine. Cutan Ocul Toxicol, 2015; 34(3):260\u2013261.","journal-title":"Cutan Ocul Toxicol"},{"issue":"3","key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/11539080-000000000-00000","article-title":"A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions","volume":"12","author":"Winnicki M","year":"2011","unstructured":"Winnicki M, , Shear NH. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions. Am J Clin Dermatol, 2011; 12(3):171\u2013180.","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.0105-1873.2004.00445.x","article-title":"Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?","volume":"51","author":"H\u00e4usermann P","year":"2004","unstructured":"H\u00e4usermann P, , Harr T, , Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis, 2004; 51(5\u20136):297\u2013310.","journal-title":"Contact Dermatitis"},{"issue":"1","key":"e_1_3_1_25_2","first-page":"89","article-title":"Systemic contact dermatitis following oral neomycin therapy","volume":"34","author":"Carnicle JM","year":"2021","unstructured":"Carnicle JM, , Tran TV, , McKissack SS. Systemic contact dermatitis following oral neomycin therapy. Proc (Bayl Univ Med Cent), 2021; 34(1):89\u201390.","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40521-014-0029-6"},{"issue":"2","key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0536.1995.tb00756.x","article-title":"Systemic contact dermatitis from thimerosal","volume":"32","author":"Zenarola P","year":"1995","unstructured":"Zenarola P, , Gimma A, , Lomuto M. Systemic contact dermatitis from thimerosal. Contact Dermatitis, 1995; 32(2):107\u2013108.","journal-title":"Contact Dermatitis"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/1203475415582306"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2008.07037"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1996.tb02116.x"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2014.12.009"},{"issue":"4","key":"e_1_3_1_32_2","first-page":"226","article-title":"Allergic contact dermatitis to polyethylene glycol and nitrofurazone","volume":"10","author":"Guijarro SC","year":"1999","unstructured":"Guijarro SC, , S\u00e1nchez-P\u00e9rez J, , Garc\u00eda-D\u00edez A. Allergic contact dermatitis to polyethylene glycol and nitrofurazone. Am J Contact Dermat, 1999; 10(4):226\u2013227.","journal-title":"Am J Contact Dermat"},{"issue":"6","key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/occmed\/kqv072","article-title":"Allergic reaction to polyethylene glycol in a painter: figure 1","volume":"65","author":"Antolin-Amerigo D","year":"2015","unstructured":"Antolin-Amerigo D, , S\u00e1nchez-Gonz\u00e1lez MJ, , Barbarroja-Escudero J, et al. Allergic reaction to polyethylene glycol in a painter: figure 1. Occup Med (Chic Ill), 2015; 65(6):502\u2013504.","journal-title":"Occup Med (Chic Ill)"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2006.00990.x"},{"issue":"5","key":"e_1_3_1_35_2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1034\/j.1600-0536.2001.440511-10.x","article-title":"Contact allergy to trometamol","volume":"44","author":"Bohn S","year":"2001","unstructured":"Bohn S, , Hurni M, , Bircher AJ. Contact allergy to trometamol. Contact Dermatitis, 2001; 44(5):308\u2013319.","journal-title":"Contact Dermatitis"},{"issue":"1","key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0536.1997.tb00368.x","article-title":"Contact allergenic activity of Tween\u00ae 80 before and after air exposure","volume":"37","author":"Bergh M","year":"1997","unstructured":"Bergh M, , Magnusson K, , Nilsson JL, et al. Contact allergenic activity of Tween\u00ae 80 before and after air exposure. Contact Dermatitis, 1997; 37(1):9\u201318.","journal-title":"Contact Dermatitis"},{"issue":"5","key":"e_1_3_1_37_2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1034\/j.1600-0536.2002.4705104.x","article-title":"Contact allergy to Tween 80 in an inhalation suspension","volume":"47","author":"Isaksson M","year":"2002","unstructured":"Isaksson M, , Jansson L. Contact allergy to Tween 80 in an inhalation suspension. Contact Dermatitis, 2002; 47(5):312\u2013313.","journal-title":"Contact Dermatitis"},{"issue":"3","key":"e_1_3_1_38_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0536.1998.tb05702.x","article-title":"Allergic contact dermatitis from disodium ethylenediamine tetra-acetic acid (EDTA) in a local anaesthetic","volume":"38","author":"Bhushan M","year":"1998","unstructured":"Bhushan M, , Beck MH. Allergic contact dermatitis from disodium ethylenediamine tetra-acetic acid (EDTA) in a local anaesthetic. Contact Dermatitis, 1998; 38(3):183.","journal-title":"Contact Dermatitis"},{"issue":"2","key":"e_1_3_1_39_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jaip.2013.12.001","article-title":"Systemic allergy to EDTA in local anesthetic and radiocontrast media","volume":"2","author":"Russo PA","year":"2014","unstructured":"Russo PA, , Banovic T, , Wiese MD, et al. Systemic allergy to EDTA in local anesthetic and radiocontrast media. J Allergy Clin Immunol Pract, 2014; 2(2):225\u2013229.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"e_1_3_1_40_2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/mds.870130113","article-title":"The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease: a histologic study","volume":"13","author":"Van Laar T","year":"1998","unstructured":"Van Laar T, , Van Hilten B, , Neef C, et al. The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease: a histologic study. Mov Disord, 1998; 13(1):52\u201355.","journal-title":"Mov Disord"},{"issue":"3","key":"e_1_3_1_41_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/cod.12084","article-title":"A case of anaphylaxis caused by polyethylene glycol analogues","volume":"69","author":"Yamasuji Y","year":"2013","unstructured":"Yamasuji Y, , Higashi Y, , Sakanoue M, et al. A case of anaphylaxis caused by polyethylene glycol analogues. Contact Dermatitis, 2013; 69(3):183\u2013185.","journal-title":"Contact Dermatitis"},{"issue":"5","key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1213\/XAA.0000000000000126","article-title":"Polyethylene glycols (PEG) and related structures: overlooked allergens in the perioperative setting","volume":"4","author":"Wenande E","year":"2015","unstructured":"Wenande E, , Kroigaard M, , Mosbech H, et al. Polyethylene glycols (PEG) and related structures: overlooked allergens in the perioperative setting. A A Case Rep, 2015; 4(5):61\u201364.","journal-title":"A A Case Rep"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/120347540400800104"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.07.013"},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","first-page":"bcr2016214563","DOI":"10.1136\/bcr-2016-214563","article-title":"DRESS syndrome potentially induced by allopurinol and triggered by influenza vaccine","volume":"2016","author":"Solak B","year":"2016","unstructured":"Solak B, , Dikicier BS, , Kara RO, et al. DRESS syndrome potentially induced by allopurinol and triggered by influenza vaccine. BMJ Case Rep, 2016; 2016:bcr2016214563.","journal-title":"BMJ Case Rep"},{"issue":"13","key":"e_1_3_1_46_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2340\/00015555-3547","article-title":"Adenovirus-induced erythema multiforme: eye and genital mucosal involvement is specific, whereas oral and cutaneous involvement is not","volume":"100","author":"Calas A","year":"2020","unstructured":"Calas A, , Lheure C, , Bernigaud C, et al. Adenovirus-induced erythema multiforme: eye and genital mucosal involvement is specific, whereas oral and cutaneous involvement is not. Acta Derm Venereol, 2020; 100(13):1\u20132.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"e_1_3_1_47_2","first-page":"583","article-title":"Erythema multiforme","volume":"57","author":"Samim F","year":"2013","unstructured":"Samim F, , Auluck A, , Zed C, et al. Erythema multiforme. A review of epidemiology, pathogenesis, clinical features, and treatment. Dent Clin N Am, 2013; 57(4):583\u2013596.","journal-title":"A review of epidemiology, pathogenesis, clinical features, and treatment. Dent Clin N Am"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05348.x"},{"issue":"6","key":"e_1_3_1_49_2","doi-asserted-by":"crossref","first-page":"e13899","DOI":"10.1111\/dth.13899","article-title":"A case of erythema multiforme major in a patient with COVID 19: the role of corticosteroid treatment","volume":"33","author":"Demirba\u015f A","year":"2020","unstructured":"Demirba\u015f A, , Elmas \u00d6F, Atasoy M, et al. A case of erythema multiforme major in a patient with COVID 19: the role of corticosteroid treatment. Dermatol Ther, 2020; 33(6):e13899.","journal-title":"Dermatol Ther"},{"issue":"4","key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"e13779","DOI":"10.1111\/dth.13779","article-title":"A fatal case of COVID-19 infection presenting with an erythema multiforme\u2013like eruption and fever","volume":"33","author":"Gargiulo L","year":"2020","unstructured":"Gargiulo L, , Pavia G, , Facheris P, et al. A fatal case of COVID-19 infection presenting with an erythema multiforme\u2013like eruption and fever. Dermatol Ther, 2020; 33(4):e13779.","journal-title":"Dermatol Ther"},{"issue":"3","key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/pde.14246","article-title":"Erythema multiforme\u2013like lesions in children and COVID-19","volume":"37","author":"Torrelo A","year":"2020","unstructured":"Torrelo A, , Andina D, , Santonja C, et al. Erythema multiforme\u2013like lesions in children and COVID-19. Pediatr Dermatol, 2020; 37(3):442\u2013446.","journal-title":"Pediatr Dermatol"},{"issue":"7","key":"e_1_3_1_52_2","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.vaccine.2019.12.028","article-title":"Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999\u20132017","volume":"38","author":"Su JR","year":"2020","unstructured":"Su JR, , Haber P, , Ng CS, et al. Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999\u20132017. Vaccine, 2020; 38(7):1746\u20131752.","journal-title":"Vaccine"},{"issue":"3","key":"e_1_3_1_53_2","first-page":"51","article-title":"The role of systemic corticosteroid therapy in erythema multiforme major and Stevens-Johnson syndrome: a review of past and current opinions","volume":"2","author":"Michaels B.","year":"2009","unstructured":"Michaels B. The role of systemic corticosteroid therapy in erythema multiforme major and Stevens-Johnson syndrome: a review of past and current opinions. J Clin Aesthet Dermatol, 2009; 2(3):51\u201355.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"7","key":"e_1_3_1_54_2","first-page":"e9405","article-title":"Stevens-Johnson syndrome due to influenza vaccination","volume":"12","author":"Tong J","year":"2020","unstructured":"Tong J, , Chan J. Stevens-Johnson syndrome due to influenza vaccination. Cureus, 2020; 12(7):e9405.","journal-title":"Cureus"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200102000-00022"},{"issue":"9","key":"e_1_3_1_56_2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0025-6196(11)62605-0","article-title":"Stevens-Johnson syndrome after immunization with smallpox, anthrax, and tetanus vaccines","volume":"79","author":"Chopra A","year":"2004","unstructured":"Chopra A, , Drage LA, , Hanson EM, et al. Stevens-Johnson syndrome after immunization with smallpox, anthrax, and tetanus vaccines. Mayo Clin Proc, 2004; 79(9):1193\u20131196.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bjps.2016.01.034","article-title":"UK guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis 2016","volume":"69","author":"Creamer D","year":"2016","unstructured":"Creamer D, , Walsh SA, , Dziewulski P, et al. UK guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis 2016. J Plast Reconstr Aesthet Surg, 2016; 69(6):736\u2013741.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"2","key":"e_1_3_1_58_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/ijd.IJD_583_17","article-title":"Management of Stevens-Johnson syndrome-toxic epidermal necrolysis: looking beyond guidelines!","volume":"63","author":"Kumar R","year":"2018","unstructured":"Kumar R, , Das A, , Das S. Management of Stevens-Johnson syndrome-toxic epidermal necrolysis: looking beyond guidelines! Indian J Dermatol, 2018; 63(2):117\u2013124.","journal-title":"Indian J Dermatol"},{"issue":"1","key":"e_1_3_1_59_2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13223-017-0222-9","article-title":"MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination","volume":"13","author":"Eindhoven S","year":"2017","unstructured":"Eindhoven S, , Levels J, , Huisman M, et al. MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination. Allergy Asthma Clin Immunol, 2017; 13(1):49.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"3","key":"e_1_3_1_60_2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/rheumatology\/kes168","article-title":"Vasculitis following HPV immunization","volume":"52","author":"Melo Gomes S","year":"2013","unstructured":"Melo Gomes S, , Glover M, , Malone M, et al. Vasculitis following HPV immunization. Rheumatology, 2013; 52(3):581\u2013582.","journal-title":"Rheumatology"},{"issue":"5","key":"e_1_3_1_61_2","doi-asserted-by":"crossref","first-page":"e20180841","DOI":"10.1542\/peds.2018-0841","article-title":"Vaccination and risk of childhood IgA vasculitis","volume":"142","author":"Piram M","year":"2018","unstructured":"Piram M, , Chiappe SG, , Madhi F, et al. Vaccination and risk of childhood IgA vasculitis. Pediatrics, 2018; 142(5):e20180841.","journal-title":"Pediatrics"},{"key":"e_1_3_1_62_2","doi-asserted-by":"crossref","first-page":"bcr2016217755","DOI":"10.1136\/bcr-2016-217755","article-title":"Leucocytoclastic vasculitis following influenza vaccination","volume":"2017","author":"Cao S","year":"2017","unstructured":"Cao S, , Sun D. Leucocytoclastic vasculitis following influenza vaccination. BMJ Case Rep, 2017; 2017:bcr2016217755.","journal-title":"BMJ Case Rep"},{"issue":"3","key":"e_1_3_1_63_2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2174\/1573397113666170517155443","article-title":"Vasculitis following influenza vaccination: a review of the literature","volume":"13","author":"Watanabe T.","year":"2017","unstructured":"Watanabe T. Vasculitis following influenza vaccination: a review of the literature. Curr Rheumatol Rev, 2017; 13(3):188\u2013196.","journal-title":"Curr Rheumatol Rev"},{"issue":"1","key":"e_1_3_1_64_2","doi-asserted-by":"crossref","first-page":"14705","DOI":"10.1038\/s41598-019-51137-5","article-title":"Kawasaki disease following administration of 13-valent pneumococcal conjugate vaccine in young children","volume":"9","author":"Yung CF","year":"2019","unstructured":"Yung CF, , Ma X, , Cheung YB, et al. Kawasaki disease following administration of 13-valent pneumococcal conjugate vaccine in young children. Sci Rep, 2019; 9(1):14705.","journal-title":"Sci Rep"},{"key":"e_1_3_1_65_2","doi-asserted-by":"crossref","first-page":"l6447","DOI":"10.1136\/bmj.l6447","article-title":"New power versus old: to beat antivaccination campaigners we need to learn from them\u2014an essay by Kathryn Perera, Henry Timms, and Jeremy Heimans","volume":"367","author":"Perera K","year":"2019","unstructured":"Perera K, , Timms H, , Heimans J. New power versus old: to beat antivaccination campaigners we need to learn from them\u2014an essay by Kathryn Perera, Henry Timms, and Jeremy Heimans. BMJ, 2019; 367:l6447.","journal-title":"BMJ"},{"issue":"3","key":"e_1_3_1_66_2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11239-020-02230-4","article-title":"COVID-19\u2013associated vasculitis and vasculopathy","volume":"50","author":"Becker RC.","year":"2020","unstructured":"Becker RC. COVID-19\u2013associated vasculitis and vasculopathy. J Thromb Thrombolysis, 2020; 50(3):499\u2013511.","journal-title":"J Thromb Thrombolysis"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200809020-00001"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_248_18"},{"issue":"2","key":"e_1_3_1_69_2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/ds.ds_1_20","article-title":"Serum sickness\u2013like reaction after diphtheria, tetanus, acellular pertussis, inactivated polio and haemophilus influenzae type B conjugate (5-in-1 vaccine) vaccination: a case report","volume":"38","author":"Chen WY","year":"2020","unstructured":"Chen WY, , Hung SJ. Serum sickness\u2013like reaction after diphtheria, tetanus, acellular pertussis, inactivated polio and haemophilus influenzae type B conjugate (5-in-1 vaccine) vaccination: a case report. Dermatol Sin, 2020; 38(2):127\u2013128.","journal-title":"Dermatol Sin"},{"issue":"1","key":"e_1_3_1_70_2","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1086\/599615","article-title":"Serum sickness\u2013like reaction associated with inactivated influenza vaccination among Thai health care personnel: risk factors and outcomes","volume":"49","author":"Apisarnthanarak A","year":"2009","unstructured":"Apisarnthanarak A, , Uyeki TM, , Miller ER, et al. Serum sickness\u2013like reaction associated with inactivated influenza vaccination among Thai health care personnel: risk factors and outcomes. Clin Infect Dis, 2009; 49(1):e18\u2013e22.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_1_71_2","doi-asserted-by":"crossref","first-page":"bcr2015211917","DOI":"10.1136\/bcr-2015-211917","article-title":"Serum sickness-like reaction after influenza vaccination","volume":"2015","author":"Chiong FJ","year":"2015","unstructured":"Chiong FJ, , Loewenthal M, , Boyle M, et al. Serum sickness-like reaction after influenza vaccination. BMJ Case Rep, 2015; 2015:bcr2015211917.","journal-title":"BMJ Case Rep"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K146"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08378.x"},{"issue":"2","key":"e_1_3_1_74_2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jaad.2004.07.061","article-title":"Acute febrile neutrophilic dermatosis (Sweet's syndrome) after influenza vaccination","volume":"52","author":"Jovanovi\u0107 M","year":"2005","unstructured":"Jovanovi\u0107 M, , Poljacki M, , Vujanovi\u0107 L, et al. Acute febrile neutrophilic dermatosis (Sweet's syndrome) after influenza vaccination. J Am Acad Dermatol, 2005; 52(2):367\u2013369.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"e_1_3_1_75_2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1525-1470.2011.01642.x","article-title":"Gianotti-Crosti syndrome after childhood vaccination","volume":"29","author":"Retrouvey M","year":"2012","unstructured":"Retrouvey M, , Koch LH, , Williams JV. Gianotti-Crosti syndrome after childhood vaccination. Pediatr Dermatol, 2012; 29(5):666\u2013668.","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"e_1_3_1_76_2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/1346-8138.13487","article-title":"Influenza vaccine\u2013induced acute generalized exanthematous pustulosis during pregnancy","volume":"44","author":"Matsuo S","year":"2017","unstructured":"Matsuo S, , Nishizawa A, , Oshio-Yoshii A, et al. Influenza vaccine\u2013induced acute generalized exanthematous pustulosis during pregnancy. J Dermatol, 2017; 44(5):598\u2013599.","journal-title":"J Dermatol"},{"issue":"1","key":"e_1_3_1_77_2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12887-017-0813-0","article-title":"Three case reports of post immunization and post viral bullous pemphigoid: looking for the right trigger","volume":"17","author":"Baroero L","year":"2017","unstructured":"Baroero L, , Coppo P, , Bertolino L, et al. Three case reports of post immunization and post viral bullous pemphigoid: looking for the right trigger. BMC Pediatr, 2017; 17(1):60.","journal-title":"BMC Pediatr"},{"key":"e_1_3_1_78_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022483"},{"issue":"10249","key":"e_1_3_1_79_2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5\u2013vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"396","author":"Zhu FC","year":"2020","unstructured":"Zhu FC, , Guan XH, , Li YH, et al. Immunogenicity and safety of a recombinant adenovirus type-5\u2013vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet, 2020; 396(10249):479\u2013488.","journal-title":"Lancet"},{"issue":"10260","key":"e_1_3_1_80_2","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1016\/S0140-6736(20)32156-5","article-title":"Use of adenovirus type-5 vectored vaccines: a cautionary tale","volume":"396","author":"Buchbinder SP","year":"2020","unstructured":"Buchbinder SP, , McElrath MJ, , Dieffenbach C, et al. Use of adenovirus type-5 vectored vaccines: a cautionary tale. Lancet, 2020; 396(10260):e68\u2013e69.","journal-title":"Lancet"},{"key":"e_1_3_1_81_2","unstructured":"Interim clinical considerations for use of mRNA COVID-19 vaccines. CDC. Available at: https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/clinical-considerations.html. Accessed February13 2021."}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000755","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1097\/DER.0000000000000755","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:05:46Z","timestamp":1777399546000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6,1]]}},"alternative-id":["10.1097\/DER.0000000000000755"],"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000755","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}